Signal Genetics Inc Stock Nasdaq
Equities
US8266401046
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | 370K 506K | Sales 2025 * | 330K 451K | Capitalization | 773M 1.06B |
---|---|---|---|---|---|
Net income 2024 * | -230M -314M | Net income 2025 * | -266M -363M | EV / Sales 2024 * | 838 x |
Net cash position 2024 * | 462M 632M | Net cash position 2025 * | 625M 854M | EV / Sales 2025 * | 448 x |
P/E ratio 2024 * |
-3.27
x | P/E ratio 2025 * |
-3.09
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.26% |
Latest transcript on Signal Genetics Inc
Managers | Title | Age | Since |
---|---|---|---|
Stephen Mahoney
CEO | Chief Executive Officer | 53 | 23-10-29 |
Seth Harmon
DFI | Director of Finance/CFO | 45 | 23-04-30 |
Thomas Ciulla
CTO | Chief Tech/Sci/R&D Officer | 59 | 22-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arlene Morris
BRD | Director/Board Member | 72 | 18-01-02 |
Tomas Kiselak
CHM | Chairman | 38 | 20-10-27 |
Stephen Mahoney
CEO | Chief Executive Officer | 53 | 23-10-29 |
1st Jan change | Capi. | |
---|---|---|
+67.53% | 62.86B | |
-0.77% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+13.30% | 26.46B | |
-22.79% | 18.9B | |
+4.70% | 12.67B | |
+24.10% | 12.27B | |
+27.41% | 12.07B |